Empliciti IV infusion 400mg, manufactured by Bristol-Myers Squibb, contains Elotuzumab (genetical recombination), a humanized IgG1 monoclonal antibody. It is used in combination with other medicines for the treatment of multiple myeloma. This 400mg bottle has a YJ code of 4291434D2027.
Empliciti IV infusion 400mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).